Hyperfine (HYPR) Cash from Investing Activities (2021 - 2026)
Hyperfine posted quarterly Cash from Investing Activities of -$242000.0 for Q1 2026, up 48.73% year-on-year from -$162712.3 in Q1 2025, and down 284.13% on a QoQ basis from -$63000.0 in Q4 2025.
Hyperfine (HYPR) has 6 years of Cash from Investing Activities data on file, last reported at -$242000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 48.73% year-over-year to -$242000.0; the trailing twelve-month figure through Mar 2026 stood at -$955000.0 (down 34.51% YoY), and the FY2025 full-year result was -$1.2 million, down 209.4% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$242000.0, down from -$63000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $54000.0 in Q2 2022 and bottomed at -$520000.0 in Q2 2025.
- The 5-year median for Cash from Investing Activities is -$159000.0 (2024), against an average of -$188176.5.
- The widest annual swing landed in 2022, when Cash from Investing Activities surged 110.69%; it then sank 687.5% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$158000.0 in 2022, then plunged by 63.29% to -$258000.0 in 2023, then soared by 96.9% to -$8000.0 in 2024, then tumbled by 687.5% to -$63000.0 in 2025, then sank by 284.13% to -$242000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$242000.0 (Q1 2026), -$63000.0 (Q4 2025), and -$130000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | -242,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -242,000.00 |
| Mar 31, 2026 | -242,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Sep 30, 2025 | -130,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Mar 31, 2025 | -472,000.00 |
| Mar 31, 2025 | -472,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Dec 31, 2024 | -8,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Sep 30, 2024 | -159,000.00 |
| Jun 30, 2024 | -71,000.00 |
| Jun 30, 2024 | -71,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | -258,000.00 |
| Dec 31, 2023 | -258,000.00 |
| Sep 30, 2023 | -263,000.00 |
| Sep 30, 2023 | -263,000.00 |
| Jun 30, 2023 | -222,000.00 |
| Jun 30, 2023 | -222,000.00 |
| Mar 31, 2023 | -61,000.00 |
| Mar 31, 2023 | -61,000.00 |
| Dec 31, 2022 | -158,000.00 |
| Dec 31, 2022 | -158,000.00 |
| Sep 30, 2022 | -173,000.00 |
| Sep 30, 2022 | -173,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Mar 31, 2022 | -308,000.00 |
| Mar 31, 2022 | -308,000.00 |
| Dec 31, 2021 | -975,000.00 |
| Dec 31, 2021 | -975,000.00 |
| Sep 30, 2021 | -1.06 Mn |
| Sep 30, 2021 | -1.06 Mn |
| Jun 30, 2021 | -505,000.00 |
| Jun 30, 2021 | -505,000.00 |
| Mar 31, 2021 | -170,000.00 |
| Mar 31, 2021 | -170,000.00 |